{"id":125750,"title":"DSEN Abstract: No evidence identified interventions that decrease the risk of adverse cardiac events for patients receiving chemotherapy and serotonin 5-hydroxytryptamine 3 receptor (5-HT3) antagonists - CIHR","sourceCode":"cihr","sourceName":"Canadian Institutes of Health Research","language":"en","captureDate":"2025-04-10","captureTimestamp":"2025-04-10T10:51:00.190000+00:00","jobId":2,"originalUrl":"https://cihr-irsc.gc.ca/e/52121.html","snippet":"DSEN Abstract: No evidence identified interventions that decrease the risk of adverse cardiac events for patients receiving chemotherapy and serotonin 5-hydroxytryptamine 3 receptor (5-HT3) antagonists - CIHR Skip to main content Skip to \"About this site\" Canada.ca Services…","rawSnapshotUrl":"/api/snapshots/raw/125750","browseUrl":"https://replay.healtharchive.ca/job-2/20250410105100/https://cihr-irsc.gc.ca/e/52121.html#ha_snapshot=125750","mimeType":"text/html","statusCode":200}